Biotechs | Market Exclusive

Home Tags Biotechs

AveXis Inc (NASDAQ:AVXS): Of Course The FDA Didn’t Ask For Placebo...

- November 3, 2016 1

Is Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) a Spanner in Sarepta Therapeutics...

- April 27, 2016 1

A Close Look at What’s Driving the Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)...

Jennifer Aldershot - April 22, 2016 0

Biotech Movers and Shakers: Portola Pharmaceuticals Inc (NASDAQ:PTLA) and United Therapeutics...

Jennifer Aldershot - March 28, 2016 0

A Tough Lesson Learnt: Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo...

- March 16, 2016 1

Synergy Sets up for a Multi-billion Dollar NDA Submission

ME Staff - January 29, 2016 0

Movers and Shakers: The Week so Far in Biotech

Jennifer Aldershot - January 26, 2016 0

Amgen is Targeting a Blockbuster SOC Upheaval in Multiple Myeloma

ME Staff - January 7, 2016 0

Today’s Biggest Movers Across the Large and Small of Biotech

- October 7, 2015 0

Biotech 101: Putting Together A Biotech Portfolio Using Your Personal Risk...

Jennifer Aldershot - September 24, 2015 0

12 Page 1 of 2

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 9, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Biotechs

AveXis Inc (NASDAQ:AVXS): Of Course The FDA Didn’t Ask For Placebo...

Is Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) a Spanner in Sarepta Therapeutics...

A Close Look at What’s Driving the Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)...

Biotech Movers and Shakers: Portola Pharmaceuticals Inc (NASDAQ:PTLA) and United Therapeutics...

A Tough Lesson Learnt: Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo...

Synergy Sets up for a Multi-billion Dollar NDA Submission

Movers and Shakers: The Week so Far in Biotech

Amgen is Targeting a Blockbuster SOC Upheaval in Multiple Myeloma

Today’s Biggest Movers Across the Large and Small of Biotech

Biotech 101: Putting Together A Biotech Portfolio Using Your Personal Risk...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY